| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.00036 | 1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |